Risk Factors and Outcomes of Carbapenem-Resistant Enterobacteriaceae Infection After Liver Transplantation: A Retrospective Study in a Chinese Population

References

• Kalpoe JS, Sonnenberg E, Factor SH, et al. Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2012;18(4):468–474. doi:10.1002/lt.2337422467548
   PubMed Web of Science ®Google Scholar
• Pereira MR, Scully BF, Pouch SM, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015;21(12):1511–1519. doi:10.1002/lt.2420726136397
   PubMed Web of Science ®Google Scholar
• Lübbert C, Becker-Rux D, Rodloff AC, et al. Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case-control analysis. Infection. 2014;42(2):309–316.24217959
   PubMed Web of Science ®Google Scholar
• Giannella M, Bartoletti M, Campoli C, et al. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Clin Microbiol Infect. 2019;25(12):1525–1531. doi:10.1016/j.cmi.2019.04.01431039445
   PubMed Web of Science ®Google Scholar
• Giannella M, Bartoletti M, Morelli MC, et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant. 2015;15(6):1708–1715. doi:10.1111/ajt.1313625754742
   PubMed Web of Science ®Google Scholar
• Freire MP, Oshiro ICVS, Pierrotti LC, et al. Carbapenem-resistant enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101(4):811–820. doi:10.1097/TP.000000000000162028009779
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. FAQs about choosing and implementing a CRE definition. Available from: https://www.cdc.gov/hai/organisms/cre/technical-info.html#Definition. Accessed 1027, 2020.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Available from: http://iacld.ir/DL/public/CLSI-2018-M100-S28.pdf. Accessed 1027, 2020.
   Google Scholar
• CDC/NHSN Surveillance Definitions for Specific Types of Infections. CDC/NHSN. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed 1027, 2020.
   Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-131478103
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):1274–1283. doi:10.1093/cid/ciu05224463280
   PubMed Web of Science ®Google Scholar
• Lübbert C, Rodloff AC, Laudi S, et al. Lessons learned from excess mortality associated with Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in liver transplant recipients. Liver Transpl. 2014;20(6):736–738. doi:10.1002/lt.2385824677425
   PubMed Web of Science ®Google Scholar
• Pouch SM, Satlin MJ. Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2017;8(4):391–402. doi:10.1080/21505594.2016.121347227470662
   PubMed Web of Science ®Google Scholar
• Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–1751. doi:10.1056/NEJM1998061133824079624195
   PubMed Web of Science ®Google Scholar
• Kim SI. Bacterial infection after liver transplantation. World J Gastroenterol. 2014;20(20):6211–6220. doi:10.3748/wjg.v20.i20.621124876741
   PubMed Web of Science ®Google Scholar
• Paya CV, Hermans PE. Bacterial infections after liver transplantation. Eur J Clin Microbiol Infect Dis. 1989;8(6):499–504.2504588
   PubMed Web of Science ®Google Scholar
• Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011;3(4):83–92. doi:10.4254/wjh.v3.i4.8321603030
   PubMedGoogle Scholar
• Kawecki D, Chmura A, Pacholczyk M, et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit. 2009;15(12):Cr628–Cr637.19946234
   PubMed Web of Science ®Google Scholar
• Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation—Part I. Liver Transpl. 2005;11(12):1452–1459. doi:10.1002/lt.2062416315310
   PubMed Web of Science ®Google Scholar
• Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17(12):1798–1803. doi:10.1111/j.1469-0691.2011.03514.x21595793
   PubMed Web of Science ®Google Scholar
• Saidel-Odes L, Polachek H, Peled N, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol. 2012;33(1):14–19. doi:10.1086/66320622173517
   PubMed Web of Science ®Google Scholar
• Oren I, Sprecher H, Finkelstein R, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control. 2013;41(12):1167–1172. doi:10.1016/j.ajic.2013.04.01824274912
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Mazzaferri F, de Smet AM, et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant gram-negative bacteria carriers. Clin Microbiol Infect. 2019;25(7):807–817. doi:10.1016/j.cmi.2019.01.00530708122
   PubMed Web of Science ®Google Scholar
• Aguado JM, Silva JT, Fernández-Ruiz M, et al. Management of multidrug resistant gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplant Rev. 2018;32(1):36–57. doi:10.1016/j.trre.2017.07.001
   Web of Science ®Google Scholar